GC wrote
"Re-rating will be based on facts and figures in next quarterly. Should company issue a report somewhere in line with expectations then current valuation will be a distant memory. Why? because the market will start to value in the profitability potential of the current operation (not currently valued at all). Matters such as exploration upside and resource/ reserve upgrades will be icing on cake."
Couldnt agree more I ended up selling AAM and moving into NAV, NAV had pritty little graphs showing recoveries, and plant throughput even though it has not been in production as long as AAM. IF JW had been prepared to quantify recoveries and plant throughput so i didnt need to second guess i would have held on to AAM, guess I just like sleeping soundly at night
- Forums
- ASX - By Stock
- AAM
- what's happening, 'bro?
what's happening, 'bro?, page-23
Featured News
Add AAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
-0.001(2.08%) |
Mkt cap ! $27.31M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.7¢ | $4.188K | 87.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 81858 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 242255 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 81858 | 0.047 |
1 | 21750 | 0.046 |
2 | 110000 | 0.045 |
1 | 4313 | 0.044 |
2 | 115833 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 242255 | 2 |
0.052 | 19249 | 1 |
0.053 | 17000 | 1 |
0.054 | 81000 | 1 |
0.055 | 443299 | 2 |
Last trade - 14.58pm 12/11/2024 (20 minute delay) ? |
Featured News
AAM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online